Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study

Hepatology - United States
doi 10.1002/hep.23050
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2016English

Cyclophilin Inhibition as a Potential Treatment for Nonalcoholic Steatohepatitis (NASH)

Expert Opinion on Investigational Drugs
MedicinePharmacology
2019English

Cytokeratin-18 Fragments for Predicting Steathohepatitis in Patients With Nonalcoholic Fatty Liver Disease

Inter Collegas
2019English

Plasma Cytokeratin-18 Concentrations as Noninvasive Biomarker of Early Gastrointestinal Toxicosis in Dogs Receiving Toceranib

Journal of Veterinary Internal Medicine
MedicineVeterinary
2018English

Nonalcoholic Steatohepatitis

English

Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Clinics in Liver Disease
Hepatology
2018English

A New Mechanism of Lipotoxicity: Calcium Channel Blockers as a Treatment for Nonalcoholic Steatohepatitis?

Hepatology
MedicineHepatology
2015English

Pathophysiology of Nonalcoholic Steatohepatitis

Juntendo Medical Journal
2017English

Circulating Microparticles as Disease-Specific Biomarkers of Severity of Inflammation in Patients With Hepatitis C or Nonalcoholic Steatohepatitis

Gastroenterology
HepatologyGastroenterology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy